Introduction of U.S. FDA mini-sentinel program Establishment of model of traditional Chinese medicine injections post-marketing safety monitoring Analysis of influencing factors on adverse reaction of Shengfu injection based on prospective active safety monitoring Construction and implementation of quality control index for clinical safety of Chinese medicine injection Necesity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections